Market Tracker

11/21 6:05pm ET

Dyax Corp (NASDAQ:DYAX)

13.27
Data as of Nov 21
 +0.05 / +0.38%
Today’s Change
6.05
Today|||52-Week Range
13.66
+76.11%
Year-to-Date
Frontrunning: November 17
Nov 17 / Investing Channel
 

Today’s Trading

Previous close13.22
Today’s open13.44
Day’s range13.02 - 13.48
Volume890,799
Average volume (3 months)1,029,773
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+56.04%
Earnings growth (next 5 years)-90.73%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book61.36

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+0.35+2.44%
ABCOAdvisory Board Co-0.03-0.07%
KERXKeryx Biopharmaceuti...+0.17+1.09%
INCRINC Research Holding...+0.97+4.29%
Data as of 4:14pm ET, 11/21/2014

Financials

Next reporting dateFebruary 18, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts